Reached Settlement for Plaintiff in Patent Case Against Eli Lilly and ImClone Related to Cancer Drug | Case Results | Robins Kaplan LLP Law Firm

June 28, 2022

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA v. ELI LILLY et al, 2:15-cv- 06133 (E.D. Pa.)

Robins Kaplan LLP represented the Trustees of the University of Pennsylvania in a complex patent infringement matter against Eli Lilly and ImClone related to the manufacture and sale of Erbitux, a blockbuster cancer drug. Penn asserted a claim of patent infringement for methods of treating cancer with the Defendants’ drug Erbitux followed by radiation. Erbitux is an antibody to EGFR. The case was resolved on confidential terms before trial.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Disclaimer

Jake M. Holdreith

Partner

Member of Executive Board

Oren D. Langer

Partner

Managing Partner, New York Office

Sharon E. Roberg-Perez, Ph.D.

Partner

Christopher A. Pinahs

Partner

Annie Huang

Partner

Deputy Managing Partner, New York Office
Pronouns: she/her

Intellectual Property and Technology Litigation Patent Litigation Software Litigation Attorneys

Business Litigation Intellectual Property and Technology Litigation Patent Litigation

Intellectual Property and Technology Litigation Hatch-Waxman Litigation Patent Litigation

Intellectual Property and Technology Litigation Copyright Litigation Entertainment and Media Litigation

Intellectual Property and Technology Litigation License Disputes Software Litigation Attorneys Copyright Litigation Trade Secret Litigation

Intellectual Property and Technology Litigation Hatch-Waxman Litigation Patent Litigation

Intellectual Property and Technology Litigation Trade Secret Litigation

Copyright Litigation Intellectual Property and Technology Litigation License Disputes Software Litigation Attorneys

Business Litigation Intellectual Property and Technology Litigation Trade Secret Litigation

Copyright Litigation Intellectual Property and Technology Litigation License Disputes Software Litigation Attorneys

Intellectual Property and Technology Litigation Name, Image, and Likeness (NIL) Disputes

Intellectual Property and Technology Litigation Patent Litigation Software Litigation Attorneys

Intellectual Property and Technology Litigation Patent Litigation Hatch-Waxman Litigation

Intellectual Property and Technology Litigation Business Litigation Trade Secret Litigation

Intellectual Property and Technology Litigation Patent Litigation

Back to Top

Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.

If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.

By accepting these terms, you are confirming that you have read and understood this important notice.